These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24364474)

  • 1. Impact of treatment with methimazole on the Bcl-2 expression in CD8+ peripheral blood lymphocytes in children with Graves' disease.
    Klatka M; Grywalska E; Polak A; Roliński J
    Ann Agric Environ Med; 2013; 20(4):884-8. PubMed ID: 24364474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes.
    Klatka M; Kaszubowska L; Grywalska E; Wasiak M; Szewczyk L; Foerster J; Cyman M; Rolinski J
    Folia Histochem Cytobiol; 2014; 52(1):69-77. PubMed ID: 24802963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 and Treg cells in adolescents with Graves' disease. Impact of treatment with methimazole on these cell subsets.
    Klatka M; Grywalska E; Partyka M; Charytanowicz M; Kiszczak-Bochynska E; Rolinski J
    Autoimmunity; 2014 May; 47(3):201-11. PubMed ID: 24443787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal distribution of gammadelta T lymphocytes in Graves' disease and insulin-dependent diabetes type 1.
    Kretowski A; Myśliwiec J; Kinalska I
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):39-42. PubMed ID: 10722230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A; Stasiak-Barmuta A; Urban M
    Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease.
    Bossowski A; Urban M; Stasiak-Barmuta A
    Pediatr Res; 2003 Sep; 54(3):425-9. PubMed ID: 12761360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment with methimazole on circulating CD4
    Hirao N; Iijima T; Tanuma D; Ohira E; Kurai H; Shinzawa T; Kase M; Sakurai S; Tomaru T; Jojima T; Usui I; Aso Y
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):841-848. PubMed ID: 35692119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of costimulatory molecules OX40/4-1BB (CD134/CD137) detection on chosen mononuclear cells in children and adolescents with Graves' disease during methimazole therapy.
    Bossowski A; Stasiak-Barmuta A; Urban M; Bossowska A
    J Pediatr Endocrinol Metab; 2005 Dec; 18(12):1365-72. PubMed ID: 16459462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease.
    Leite AC; Pedro AB; Romaldini JH
    Horm Metab Res; 2011 Mar; 43(3):194-9. PubMed ID: 21283953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease.
    Inukai Y; Momobayashi A; Sugawara N; Aso Y
    Eur J Endocrinol; 2007 Jun; 156(6):623-30. PubMed ID: 17535861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Thyroid; 2013 Nov; 23(11):1461-9. PubMed ID: 23721189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of methimazole treatment on magnesium concentration and lymphocytes activation in adolescents with Graves' disease.
    Klatka M; Grywalska E; Partyka M; Charytanowicz M; Rolinski J
    Biol Trace Elem Res; 2013 Jun; 153(1-3):155-70. PubMed ID: 23661330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of very late antigen-4 and lymphocyte function-associated antigen-1 on peripheral blood lymphocytes from patients with graves disease.
    Bossowski A; Urban M; Stasiak-Barmuta A; Turowski D
    Pediatr Res; 2002 Oct; 52(4):533-7. PubMed ID: 12357047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
    Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
    Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
    Gessl A; Waldhäusl W
    Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.